MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

CI · NYSE

The Cigna Group

Health Care · Medical Specialities

Reference price$301.06As of Jul 28, 2026
Market capitalization$79.64B
52-week range$239.51–$315.47
S&P 500 portfolio weight0.12%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$302.00+0.3% vs. reference
Average$343.40+14.1% vs. reference
High$400.00+32.9% vs. reference
13 Buy3 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportJul 30, 2026Jun 2026
Consensus EPS$7.586 estimates
Expected range$7.55–$7.61Low to high EPS
Dec 2026$30.39Street EPS consensus
Dec 2027$33.41Street EPS consensus
Dec 2028$36.40Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+11.2% YoY$275B$247B
Operating income$9.2B$9.42B
Net income$5.96B$3.43B
Operating cash flow$9.6B$10.36B
Capital expenditures($1.21B)($1.41B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Will Declining Medical Customers Affect Cigna's Q2 Earnings?

Zacks

Seeking Clues to Cigna (CI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

BNK Invest

Daily Dividend Report: IBM,LMT,SIRI,CI,BLK,CMCSA

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.